NCT03019133

Brief Summary

The goal of the project is to determine the effects of noise masking and noise reduction on stress related physiological parameters in critically ill patients admitted to the intensive care unit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 19, 2016

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 12, 2017

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 6, 2025

Status Verified

March 1, 2025

Enrollment Period

8.1 years

First QC Date

December 19, 2016

Last Update Submit

April 3, 2025

Conditions

Keywords

Heart rateBlood pressure variability

Outcome Measures

Primary Outcomes (1)

  • Nocturnal LF/HF ratio (a.u.)

    The effect of group assignment on nocturnal (8pm to 8am) low frequency/high frequency (LF/HF) ratio will be determined.

    Day 1 of study

Secondary Outcomes (8)

  • Nocturnal heart rate (bpm)

    Day 1 of study

  • Nocturnal RMSSD (ms)

    Day 1 of study

  • Nocturnal blood pressure (mm Hg)

    Day 1 of study

  • Incidence of ICU delirium

    Assessed at the time of ICU discharge up to a maximum of 28 days after enrollment, and averaging 4 days after enrollment

  • Hospital length of stay (days)

    Assessed at the time of hospital discharge up to a maximum of 28 days after enrollment, and averaging 6 days after enrollment.

  • +3 more secondary outcomes

Other Outcomes (1)

  • Intra-individual nocturnal LF/HF ratio (a.u.)

    Days 1 and 2 of study

Study Arms (3)

Usual Care

NO INTERVENTION

Usual care will be provided.

Sound reduction

ACTIVE COMPARATOR

Use of noise reduction headphones. Pro For Sho safety ear muffs with a noise reduction rate of 34dB will be used.

Device: Sound reduction

Sound masking

ACTIVE COMPARATOR

Use of headphones and relaxing music. Sennheiser HD 280 pro headphones will be used for sound masking.

Device: Sound masking

Interventions

Subjects will wear noise reduction headphones between the hours of 8:00 pm and 8:00 am.

Sound reduction

Subjects will wear wear headphones playing relaxing music between the hours of 8:00 pm and 8:00 am.

Sound masking

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects aged 18-99 years who are expected to receive care on an adult critical care unit for at least 24 hours

You may not qualify if:

  • Admission for drug overdose or with a known substance abuse disorder
  • Untreated sleep apnea disorder, narcolepsy, REM sleep behavior disorder, parasomnia, restless leg syndrome or other sleep disorder
  • Use of hearing aids, or known significant conductive or sensory hearing loss
  • Ventilator support via an endotracheal tube
  • Use of vasopressors
  • Unresponsive or delirious
  • Subjects with known Dementia, Parkinson's disease, or other neurodegenerative disorder
  • Subjects with a pacemaker or who have received cardiac transplant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa Hospitals and Clinics

Iowa City, Iowa, 52242, United States

Location

MeSH Terms

Conditions

Critical IllnessDeliriumSleep Deprivation

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsNeurocognitive DisordersMental DisordersDyssomniasSleep Wake Disorders

Study Officials

  • Brian K Gehlbach, MD

    Faculty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

December 19, 2016

First Posted

January 12, 2017

Study Start

December 1, 2016

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

As this is a pilot study, there are no definite plans for sharing individual participant data at this time.

Available IPD Datasets

Informed Consent Form (201609843)Access

Locations